RYBREVANT
AMIVANTAMAB
Public price
15,29 MAD
Active substance
AMIVANTAMAB
Laboratory
MAPHAR
What is this medicine?
RYBREVANT contains AMIVANTAMAB. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
AMIVANTAMAB, SOLUTION A DILUER POUR PERFUSION, 350 MG, BOITE D’UN FLACON DE 7 ML DE SOLUTION
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Laboratory
MAPHAR
Hospital price
15,00 MAD
Strength
350 MG
Form
SOLUTION A DILUER POUR PERFUSION
Presentation
BOITE D’UN FLACON DE 7 ML DE SOLUTION
Commercial status
Commercialisé
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 15,29 MAD